Review
doi: 10.1111/j.1572-0241.2006.00864_1.x.
Pro: esophagectomy is the treatment of choice for high-grade dysplasia in Barrett's esophagus
Affiliations
- PMID: 17032178
- DOI: 10.1111/j.1572-0241.2006.00864_1.x
Item in Clipboard
Review
Pro: esophagectomy is the treatment of choice for high-grade dysplasia in Barrett's esophagus
Am J Gastroenterol.
2006 Oct.
No abstract available
Comment in
-
CON: surgery for Barrett's with flat HGD-no!Am J Gastroenterol. 2006 Oct;101(10):2180-3. doi: 10.1111/j.1572-0241.2006.00864_2.x. Am J Gastroenterol. 2006. PMID: 17032179 Review. No abstract available.
-
A balancing view: an individualized approach to high-grade dysplasia is key: esophagectomy, surveillance, or endoscopic therapy should all be considered.Am J Gastroenterol. 2006 Oct;101(10):2183-4. doi: 10.1111/j.1572-0241.2006.00864_3.x. Am J Gastroenterol. 2006. PMID: 17032180 Review. No abstract available.
Similar articles
-
Treatment of Barrett's esophagus with high-grade dysplasia.Expert Rev Anticancer Ther. 2009 Mar;9(3):303-16. doi: 10.1586/14737140.9.3.303. Expert Rev Anticancer Ther. 2009. PMID: 19275509 Review.
-
New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.Ann Thorac Surg. 2008 Feb;85(2):S747-50. doi: 10.1016/j.athoracsur.2007.10.102. Ann Thorac Surg. 2008. PMID: 18222209 Review. No abstract available.
-
Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.Surg Oncol Clin N Am. 2009 Jul;18(3):523-31. doi: 10.1016/j.soc.2009.03.008. Surg Oncol Clin N Am. 2009. PMID: 19500741 Review.
-
Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):493-8. doi: 10.1586/egh.09.44. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19817671 Review.
-
CON: surgery for Barrett's with flat HGD-no!Am J Gastroenterol. 2006 Oct;101(10):2180-3. doi: 10.1111/j.1572-0241.2006.00864_2.x. Am J Gastroenterol. 2006. PMID: 17032179 Review. No abstract available.
Cited by
-
Prevalence of adenocarcinoma at esophagectomy for Barrett's esophagus with high grade dysplasia.J Gastrointest Oncol. 2011 Mar;2(1):34-8. doi: 10.3978/j.issn.2078-6891.2010.027. J Gastrointest Oncol. 2011. PMID: 22811825 Free PMC article.
-
Decreasing morbidity and mortality in 100 consecutive minimally invasive esophagectomies.Surg Endosc. 2012 Jan;26(1):162-7. doi: 10.1007/s00464-011-1846-3. Epub 2011 Jul 27. Surg Endosc. 2012. PMID: 21792712
-
Risk for cancer in Barrett's esophagus: medical versus surgical therapy.Curr Gastroenterol Rep. 2007 Jun;9(3):189-94. doi: 10.1007/s11894-007-0017-0. Curr Gastroenterol Rep. 2007. PMID: 17511915 Review.
-
Update on staging and surgical treatment options for esophageal cancer.J Gastrointest Surg. 2011 May;15(5):719-29. doi: 10.1007/s11605-011-1515-9. J Gastrointest Surg. 2011. PMID: 21487832 Review.
-
Low risk of prevalent submucosal invasive cancer among patients undergoing esophagectomy for treatment of Barrett's esophagus with high grade dysplasia.J Gastrointest Oncol. 2011 Mar;2(1):1-4. doi: 10.3978/j.issn.2078-6891.2011.005. J Gastrointest Oncol. 2011. PMID: 22811818 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
